PRINS RICHARD K

SEC Form 4 insider trading activity

PRINS RICHARD K has filed 5 SEC Form 4 filings (8 transaction rows) across 2 companies, including AMPH, IGC, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Aug 12, 2026.

On the most recent filing, PRINS RICHARD K is listed as Director at Amphastar Pharmaceuticals, Inc. Inside the rolling window, PRINS RICHARD K reported no open-market purchases and 2 open-market sales totaling $275K in AMPH. The largest disclosed transaction in the window is a sale of 7,973 AMPH shares on Aug 11, 2026, worth $162K.

Companies traded

Other insiders at AMPH

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$275K

reported sales (SEC code S)

Companies

2

in the rolling window

Source
AMPHSale$162KAug 12SEC ↗
AMPHSale$113KNov 25SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has PRINS RICHARD K made?

PRINS RICHARD K has filed 5 SEC Form 4 filings (8 transaction rows) across 2 companies, including AMPH, IGC since 2025.

Which companies does PRINS RICHARD K trade?

PRINS RICHARD K has filed SEC Form 4 disclosures for 2 companies, including AMPH, IGC.

When was PRINS RICHARD K's most recent SEC Form 4 filing?

PRINS RICHARD K's most recent SEC Form 4 filing on Tracefour is dated Aug 12, 2026.

What is PRINS RICHARD K's total buy and sell value in the current window?

Inside the rolling retention window, PRINS RICHARD K bought $0 and sold $275K based on SEC Form 4 filings.

What was PRINS RICHARD K's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 7,973 AMPH shares on 2026-08-11, worth $162K, per SEC Form 4 filings.